AHA GUIDELINES Bundle (free trial)

Chronic Coronary Disease 2023

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1504138

Contents of this Issue

Navigation

Page 50 of 65

51 Table 19. Nonatherosclerotic Causes of CCD in Young Adults: Evaluation and Management Cause Presentation Management Kawasaki's disease Late sequelae: coronary artery aneurysm, stenosis, thrombosis, or fistula • Lifelong follow-up with quantitative assessment of luminal dimensions. • Low-dose aspirin therapy for small- or medium-sized coronary artery aneurysms. • Low-dose aspirin plus anticoagulant therapy for large coronary artery aneurysms. Coronary artery anomalies • Anomalous left coronary artery from the pulmonary artery • Anomalous origin of the coronary artery from the opposite sinus of Valsalva with an interarterial course • Surgical repair — translocation of left coronary artery to aortic root for anomalous left coronary artery from the pulmonary artery. • Surgical correction among young adults with interarterial course of coronary artery originating from opposite sinus of Valsalva and symptoms during exercise suggestive of myocardial ischemia. Myocardial bridging • Exercise-induced ischemia • Coronary artery vasospasm • Sudden cardiac death • Beta-adrenergic blocking agents in symptomatic patients. • Restriction to low-intensity sports. • Surgical correction if symptoms refractory to medical therapy. 6.4. Cancer COR LOE Recommendation 1 C-LD 1. In patients with CCD and cancer, a multidisciplinary team including cardiolog y and oncolog y expertise is recommended to improve long-term CVD outcomes.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Chronic Coronary Disease 2023